A Study to Evaluate the Effect of Precision Spectra™ Programming Features and Lead Options on Patient Outcomes
TerminatedNot applicableNCT02384096
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
The study is a prospective, on-label, multi-center, blinded, randomized controlled trial with a cross-over design to evaluate the effect of Precision Spectra™ SCS System's programming features and lead options.
Study details
- Official title
- COVERAGE - A Study to Evaluate the Effect of Precision Spectra™ SCS System's Programming Features and Lead Options on Patient Outcomes
- Conditions
- Interventions
- Device: Conventional single source programming
- Device: Precision Spectra SCS System advanced programming
- Sponsor
- Boston Scientific Corporation
- Start date
- 2015-02
- Primary completion
- 2016-10
- Sex
- All
- Age range
- from 18 Years
- Results posted
- Yes, on ClinicalTrials.gov
- Countries
- United States
- Total sites listed
- 4
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Meets RELIEF Registry criteria for inclusion * Primary complaint of persistent or recurrent low back pain, with or without leg pain * Signed a valid, IRB/EC-approved informed consent form Exclusion Criteria: * Meets any RELIEF Registry criteria for exclusion
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT02384096